Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage

NCT00949364 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT00949364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
Lead sponsor
University of Ulm
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
December 14, 2016
Enrollment
103 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative neoplasms